US Stock MarketDetailed Quotes

PLRX Pliant Therapeutics

Watchlist
  • 14.000
  • +0.270+1.97%
Close Oct 15 16:00 ET
  • 14.000
  • 0.0000.00%
Post 16:08 ET
851.22MMarket Cap-4530P/E (TTM)

Pliant Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
-83.69%1.58M
0
0
-95.03%248K
6.65%1.33M
27.91%9.69M
-1.70%1.97M
-7.95%1.48M
Operating revenue
--0
--0
-83.69%1.58M
--0
--0
-95.03%248K
6.65%1.33M
27.91%9.69M
-1.70%1.97M
-7.95%1.48M
Cost of revenue
Gross profit
Operating expense
27.46%60.64M
20.64%52.39M
35.68%185.73M
19.49%47.04M
42.65%47.69M
37.38%47.58M
47.41%43.43M
30.23%136.89M
48.00%39.37M
16.38%33.43M
Selling and administrative expenses
3.07%15.02M
7.72%15.25M
45.00%57.93M
-2.79%13.85M
73.93%15.35M
75.68%14.57M
64.98%14.15M
44.96%39.95M
81.63%14.25M
15.02%8.82M
-General and administrative expense
3.07%15.02M
7.72%15.25M
45.00%57.93M
-2.79%13.85M
73.93%15.35M
75.68%14.57M
64.98%14.15M
44.96%39.95M
81.63%14.25M
15.02%8.82M
Research and development costs
38.22%45.62M
26.90%37.15M
31.84%127.8M
32.13%33.18M
31.43%32.34M
25.32%33M
40.19%29.27M
25.00%96.94M
33.93%25.11M
16.88%24.61M
Operating profit
-28.13%-60.64M
-24.46%-52.39M
-44.77%-184.15M
-25.77%-47.04M
-49.26%-47.69M
-59.67%-47.33M
-49.21%-42.1M
-30.41%-127.2M
-52.04%-37.4M
-17.83%-31.95M
Net non-operating interest income expense
-22.02%4.79M
19.57%5.44M
488.01%22.81M
153.33%5.93M
365.32%6.2M
6,291.67%6.14M
3,996.40%4.55M
1,326.10%3.88M
3,341.18%2.34M
1,858.82%1.33M
Non-operating interest income
-12.42%5.65M
21.08%5.88M
415.55%24.08M
135.19%6.25M
298.96%6.52M
2,299.63%6.46M
4,276.58%4.86M
1,616.91%4.67M
--2.66M
--1.63M
Non-operating interest expense
172.10%868K
43.09%445K
60.18%1.27M
1.26%321K
5.32%317K
84.39%319K
--311K
--791K
--317K
--301K
Other net income (expense)
Income before tax
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
-26.79%-123.32M
-42.92%-35.06M
-13.20%-30.62M
Income tax
Net income
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
-26.79%-123.32M
-42.92%-35.06M
-13.20%-30.62M
Net income continuous Operations
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
-26.79%-123.32M
-42.92%-35.06M
-13.20%-30.62M
Minority interest income
Net income attributable to the parent company
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
-26.79%-123.32M
-42.92%-35.06M
-13.20%-30.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
-26.79%-123.32M
-42.92%-35.06M
-13.20%-30.62M
Basic earnings per share
-31.43%-0.92
-16.42%-0.78
6.46%-2.75
4.17%-0.69
-7.69%-0.7
14.63%-0.7
14.10%-0.67
-8.49%-2.94
-5.88%-0.72
13.33%-0.65
Diluted earnings per share
-31.43%-0.92
-16.42%-0.78
6.46%-2.75
4.17%-0.69
-7.69%-0.7
14.63%-0.7
14.10%-0.67
-8.49%-2.94
-5.88%-0.72
13.33%-0.65
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 00-83.69%1.58M00-95.03%248K6.65%1.33M27.91%9.69M-1.70%1.97M-7.95%1.48M
Operating revenue --0--0-83.69%1.58M--0--0-95.03%248K6.65%1.33M27.91%9.69M-1.70%1.97M-7.95%1.48M
Cost of revenue
Gross profit
Operating expense 27.46%60.64M20.64%52.39M35.68%185.73M19.49%47.04M42.65%47.69M37.38%47.58M47.41%43.43M30.23%136.89M48.00%39.37M16.38%33.43M
Selling and administrative expenses 3.07%15.02M7.72%15.25M45.00%57.93M-2.79%13.85M73.93%15.35M75.68%14.57M64.98%14.15M44.96%39.95M81.63%14.25M15.02%8.82M
-General and administrative expense 3.07%15.02M7.72%15.25M45.00%57.93M-2.79%13.85M73.93%15.35M75.68%14.57M64.98%14.15M44.96%39.95M81.63%14.25M15.02%8.82M
Research and development costs 38.22%45.62M26.90%37.15M31.84%127.8M32.13%33.18M31.43%32.34M25.32%33M40.19%29.27M25.00%96.94M33.93%25.11M16.88%24.61M
Operating profit -28.13%-60.64M-24.46%-52.39M-44.77%-184.15M-25.77%-47.04M-49.26%-47.69M-59.67%-47.33M-49.21%-42.1M-30.41%-127.2M-52.04%-37.4M-17.83%-31.95M
Net non-operating interest income expense -22.02%4.79M19.57%5.44M488.01%22.81M153.33%5.93M365.32%6.2M6,291.67%6.14M3,996.40%4.55M1,326.10%3.88M3,341.18%2.34M1,858.82%1.33M
Non-operating interest income -12.42%5.65M21.08%5.88M415.55%24.08M135.19%6.25M298.96%6.52M2,299.63%6.46M4,276.58%4.86M1,616.91%4.67M--2.66M--1.63M
Non-operating interest expense 172.10%868K43.09%445K60.18%1.27M1.26%321K5.32%317K84.39%319K--311K--791K--317K--301K
Other net income (expense)
Income before tax -35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M-35.51%-41.49M-39.42%-41.19M-33.62%-37.55M-26.79%-123.32M-42.92%-35.06M-13.20%-30.62M
Income tax
Net income -35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M-35.51%-41.49M-39.42%-41.19M-33.62%-37.55M-26.79%-123.32M-42.92%-35.06M-13.20%-30.62M
Net income continuous Operations -35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M-35.51%-41.49M-39.42%-41.19M-33.62%-37.55M-26.79%-123.32M-42.92%-35.06M-13.20%-30.62M
Minority interest income
Net income attributable to the parent company -35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M-35.51%-41.49M-39.42%-41.19M-33.62%-37.55M-26.79%-123.32M-42.92%-35.06M-13.20%-30.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M-35.51%-41.49M-39.42%-41.19M-33.62%-37.55M-26.79%-123.32M-42.92%-35.06M-13.20%-30.62M
Basic earnings per share -31.43%-0.92-16.42%-0.786.46%-2.754.17%-0.69-7.69%-0.714.63%-0.714.10%-0.67-8.49%-2.94-5.88%-0.7213.33%-0.65
Diluted earnings per share -31.43%-0.92-16.42%-0.786.46%-2.754.17%-0.69-7.69%-0.714.63%-0.714.10%-0.67-8.49%-2.94-5.88%-0.7213.33%-0.65
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data